A Study of MK-8527 in Human Immunodeficiency Type 1 Virus (HIV-1) Infected Participants (MK-8527-002)
Clinical trial NCT03615183 · COMPLETED
Trial details
- NCT number
- NCT03615183
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-11
- Primary completion
- 2019-09-26
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.